Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38MAPK/CK2 signaling in human breast cancer cells

Dose-Dependency of Resveratrol in Providing Health Benefits

(2010) Subhendu Mukherjee et al.   Dose-Response

Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305

(2009) Cinzia Giordano et al.   BREAST CANCER RESEARCH AND TREATMENT

Transcriptional Regulation of Estrogen Receptor-  by p53 in Human Breast Cancer Cells

(2009) S. H. Shirley et al.   CANCER RESEARCH

Evidence that Bergapten, Independently of its Photoactivation, Enhances p53 Gene Expression and Induces Apoptosis in Human Breast Cancer Cells

(2009) M. Panno et al.   CURRENT CANCER DRUG TARGETS

Progesterone Receptor B Recruits a Repressor Complex to a Half-PRE Site of the Estrogen Receptor α Gene Promoter

(2009) F. De Amicis et al.   MOLECULAR ENDOCRINOLOGY

G Protein-Coupled Receptor 30 Expression Is Up-Regulated by EGF and TGFα in Estrogen Receptor α-Positive Cancer Cells

(2009) Adele Vivacqua et al.   MOLECULAR ENDOCRINOLOGY